Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-02-21Prostate Biopsy Access Needle & Needle Guide Feasibility Study
-
CLINICAL_TRIALS study record update · 2022-02-18Randomized Study of Ultralow Versus Standard Pneumoperitoneum Pressure During Robotic Prostatectomy Using the AirSeal® Insufflation System
-
CLINICAL_TRIALS study record update · 2022-02-17Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay
-
CLINICAL_TRIALS study record update · 2022-02-17A Phase II Study of Sorafenib in Combination With Docetaxel in Patients With Androgen-Independent Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-02-17An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-14Clinical Evaluation of the Benefits of the MiProstate Platform: Follow-up Study
-
CLINICAL_TRIALS study record update · 2022-02-10Reduction of Prostate Biopsy Morbidity and Hospitalization Through a Modified Biopsy Protocol Bundle and Region-specific Antibiogram
-
CLINICAL_TRIALS study record update · 2022-02-09A Phase 2 Study of Nivolumab in Combination With Either Rucaparib, Docetaxel, or Enzalutamide in Men With Castration-resistant Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-02-09Phase I Study of Stereotactic Body Radiation Therapy (SBRT) for Organ Confined Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-02-08Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD009, A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART) Protein in Patients With Unresectable or Metastatic B7-H3-Expressing Neoplasms
-
CLINICAL_TRIALS study record update · 2022-02-08A Phase 1 Dose Escalation Study of MGA271 in Refractory Cancer
-
CLINICAL_TRIALS study record update · 2022-02-08A Prospective Trial of Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
-
CLINICAL_TRIALS study record update · 2022-02-03BrUOG 337: Olaparib Prior to Radical Prostatectomy For Patients With Locally Advanced Prostate Cancer and Defects in DNA Repair Genes
-
CLINICAL_TRIALS study record update · 2022-02-03Biomarker-Driven Phase-2 Study of Combined Immune Checkpoint Blockade for AR-V7-Expressing Metastatic Castration-Resistant Prostate Cancer (STARVE-PC)
-
CLINICAL_TRIALS study record update · 2022-02-02Race-related Alternative Splicing: Novel Targets in Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-02-01MR Image Guided Focal Therapy in Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-01-26Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy
-
CLINICAL_TRIALS study record update · 2022-01-24A Phase II Study of Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer Using Continuous Real-time Evaluation of Prostate Motion and IMRT Plan Reoptimization Based on the Anatomy of the Day
-
CLINICAL_TRIALS study record update · 2022-01-21Expanded Access [Ga-68] PSMA-11 PET Imaging
-
CLINICAL_TRIALS study record update · 2022-01-20Impact of Yoga As Complementary Therapy on Quality of Life, Pro-inflammatory, and Cellular Immune Biomarkers in Patients Undergoing Radical Prostatectomy: A Pilot Randomized-Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-01-18A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
-
CLINICAL_TRIALS study record update · 2022-01-18A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
-
CLINICAL_TRIALS study record update · 2022-01-18A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
-
CLINICAL_TRIALS study record update · 2022-01-12Study to Evaluate Physician Awareness and Knowledge of Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Monotherapies in Europe: an Observational Post-Authorisation Joint Safety Study (Safe-CAM)
-
CLINICAL_TRIALS study record update · 2022-01-12Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial